225 related articles for article (PubMed ID: 2109852)
1. Home self-administration of intravenous immunoglobulin therapy in children.
Kobayashi RH; Kobayashi AD; Lee N; Fischer S; Ochs HD
Pediatrics; 1990 May; 85(5):705-9. PubMed ID: 2109852
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin: a review.
Eibl MM; Wedgwood RJ
Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases.
Stein MR; Koterba A; Rodden L; Berger M
Postgrad Med; 2011 Sep; 123(5):186-93. PubMed ID: 21904101
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal antibody levels in children with PID receiving immunoglobulin.
Tuerlinckx D; Florkin B; Ferster A; De Schutter I; Chantrain C; Haerynck F; Philippet P; Strengers P; Laub R
Pediatrics; 2014 Jan; 133(1):e154-62. PubMed ID: 24366995
[TBL] [Abstract][Full Text] [Related]
5. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.
Gardulf A; Nicolay U; Math D; Asensio O; Bernatowska E; Böck A; Costa-Carvalho BT; Granert C; Haag S; Hernández D; Kiessling P; Kus J; Matamoros N; Niehues T; Schmidt S; Schulze I; Borte M
J Allergy Clin Immunol; 2004 Oct; 114(4):936-42. PubMed ID: 15480339
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy.
Gardulf A; Borte M; Ochs HD; Nicolay U;
Clin Immunol; 2008 Jan; 126(1):81-8. PubMed ID: 17964220
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
Shapiro RS
Pediatr Allergy Immunol; 2013 Feb; 24(1):49-53. PubMed ID: 23331529
[TBL] [Abstract][Full Text] [Related]
8. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G.
Berger M; Murphy E; Riley P; Bergman GE;
South Med J; 2010 Sep; 103(9):856-63. PubMed ID: 20689467
[TBL] [Abstract][Full Text] [Related]
9. Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies.
Abrahamsen TG; Sandersen H; Bustnes A
Pediatrics; 1996 Dec; 98(6 Pt 1):1127-31. PubMed ID: 8951264
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiency.
Fasth A; Nyström J
Acta Paediatr; 2007 Oct; 96(10):1474-8. PubMed ID: 17850391
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of subcutaneous versus intravenous IgG replacement therapy in pediatric patients with primary immunodeficiency diseases: a multicenter study in Argentina.
Bezrodnik L; Gómez Raccio A; Belardinelli G; Regairaz L; Díaz Ballve D; Seminario G; Moreira I; Riganti C; Cantisano C; Díaz H; Di Giovanni D
J Clin Immunol; 2013 Oct; 33(7):1216-22. PubMed ID: 23846854
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
Jolles S; Bernatowska E; de Gracia J; Borte M; Cristea V; Peter HH; Belohradsky BH; Wahn V; Neufang-Hüber J; Zenker O; Grimbacher B
Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277
[TBL] [Abstract][Full Text] [Related]
13. Serum IgG subclass concentrations before and after administration of intravenous immunoglobulin in common variable immunodeficiency.
Ozawa T; Motoyoshi F; Kato Y; Kondo N; Orii T
J Clin Lab Immunol; 1992; 38(1):29-39. PubMed ID: 1343346
[TBL] [Abstract][Full Text] [Related]
14. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.
Orange JS; Grossman WJ; Navickis RJ; Wilkes MM
Clin Immunol; 2010 Oct; 137(1):21-30. PubMed ID: 20675197
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of patients with primary antibody deficiencies in Germany].
Borte M; Oertelt C; Högy B
Klin Padiatr; 2005; 217(5):276-80. PubMed ID: 16167275
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a new intravenous immunoglobulin preparation in primary immunodeficient patients.
Ochs HD; Lee ML; Fischer SH; Kingdon HS; Wedgwood RJ
Clin Ther; 1987; 9(5):512-22. PubMed ID: 3117369
[TBL] [Abstract][Full Text] [Related]
17. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
Günther G; Dreger B
Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
[TBL] [Abstract][Full Text] [Related]
18. Prenatal and postnatal prophylaxis of infections in preterm neonates.
von Muralt G; Sidiropoulos D
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S72-8. PubMed ID: 3135529
[TBL] [Abstract][Full Text] [Related]
19. Treatment with gammaglobulin preparation for intravenous use in children with humoral immunodeficiency: clinical and immunologic follow-up.
Galli E; Barbieri C; Cantani A; Solano A; Longhi MA; Businco L
Ann Allergy; 1990 Feb; 64(2 Pt 1):147-50. PubMed ID: 2106278
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysis.
Shapiro RS
Ann Allergy Asthma Immunol; 2013 Jul; 111(1):51-5. PubMed ID: 23806460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]